Weight Loss Injections: 2025 Update – Mounjaro, Ozempic & the Evolving Evidence

These GLP-1 receptor agonists, originally designed to manage type 2 diabetes, have revolutionized the way we approach weight loss, but as more people embark on treatment, we’re learning more about their long-term effects, limitations, and best practices.